Interested in learning about the evolution of Point-of-Care molecular diagnostics? This article provides a very good overview of an area that is attracting both public and private funding and also points out the substantial growth anticipated for this market. Some of the key market drivers include:
Medication nonadherence has long been a major issue for health and healthcare costs. According to one study, “Patient nonadherence to prescribed medications is associated with poor therapeutic outcomes, progression of disease, and an estimated burden of billions per year in avoidable direct health care costs.”
Last night MOHAI hosted an event called “Seattle 20/20: Innovation and Impact” which included a panel of Seattle leaders in a conversation about our region's future as a global innovation hub. It was moderated by John Cook, Co-founder of GeekWire and included Vikram Jandhyala, UW Vice Provost for Innovation and Executive Director of CoMotion; Michael C. Jensen, MD, Director, Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute; Michael Schutzler, CEO, Washington Technology Industry Association; and Dawn Trudeau, Co-Owner, Seattle Storm.
Stratos got the opportunity to host a tour for about twenty 8th grade students. The tour was part of a program called “Making Connections” held by the University of Washington’s Women’s Center. It is a college-readiness program that aims to increase interest in the Science, Technology, Engineering, and Math (STEM) fields.
It’s not lost on us here at Stratos that we are really lucky to have a team of really talented designers and engineers. But what’s even more impressive is the longevity of that team – the average tenure of a Stratos engineer is close to 10 years and we have a significant number who have been with us for well over 15 years.
Day one at the WBBA’s Life Sciences Innovation Northwest conference was an educational experience to be sure. There were a wide variety of topics covered across the life sciences, including medical technologies, biopharmaceuticals, therapeutics, investments, health IT and much more.
With increased competition, a shortage of qualified hardware and software engineers, and new markets rapidly developing, many leading medical device and technology makers are having a hard time staffing their R&D demands.